41 results about "Treated group" patented technology

Systems and methods for evaluating prospective treatments for progressive brain disorders like Alzheimer's disease and the progressive effects of aging involve the use of an imaging device communicatively coupled to a computing device. The imaging device may takes a plurality of brain imaging measurements from each of a plurality of human subjects who are divided into a treated group and an untreated group based on various subject data including whether the subjects carry certain alleles of genes known to increase the risk of developing the brain disorder at issue. The computing device receives the brain imaging measurements from the imaging device and applies an advanced processing method that permits enhanced computational efficiency when calculating rates of change for the two groups and determining whether any calculated difference between the rates is statistically significant.

The invention discloses a traditional Chinese medicine composition for treating acute mastitis. The traditional Chinese medical science considers that the pathogenesis of the acute mastitis mainly comprises milk accumulation, poor circulation of blood and qi, breast collateral impairment, and heat-transmission and pus-production caused by storing milk for a long time. Therefore, a decoction provided by the invention is prepared by the traditional Chinese medicines: radix berberidis, uniflower swisscentaury root, ampelopsis cantoniensis, rhizome anemarrhenae, caulis trachelospermi, gynura pseudo-china, trogopterus dung, cowherb seed, rhizoma atractylodis macrocephalae, pericarpium citri reticulatae viride and dendrobe which have the effects of clearing away heat and toxic materials, promoting blood circulation to remove blood stasis, and dredging collaterals and removing stasis. Through the clinical tests, the total effective rate reaches up 97.3%, which is significantly higher than that of a control group; and the breast pain and breast lumps in the two groups after treatment are remarkably relieved compared with the conditions of the breast pain and breast lumps before the treatment, and the improvement degree of the treated group is superior to that of the control group. The invention has the advantages that the taking is simple, the treatment cost is low, and no side effect is caused after taking, and is worth popularizing and applying.

The invention relates to a method for promoting growth of Poacynum pictum by inoculating arbuscular mycorrhizal fungi. The method comprises the following steps: collecting and processing seeds; sprouting and inoculating; observing the growth situation; measuring infection. An experimental result proves that the four important growth indexes, namely, average plant height, average growth rate, cluster width and leaf number of the Poacynum pictum plant, after the Glomus mosseae is inoculated with Poacynum pictum, are obviously higher than the four important growth indexes of two non-inoculating contrast groups and other AM fungi treating groups. Meanwhile, the infection rate and infection strength of the Glomus mosseae to the Poacynum pictum are higher than the infection rate and infection strength to all the other treating groups, so that the growth for the strain after the Glomus mosseae is inoculated with Poacynum pictum is obviously boosted.

The invention discloses an application with anti-intercellular sticking molecule-1 single antibody to prepare the medicine to treat fowl flu, which is characterized by the following: adopting H5N1 hypotype fowl flu mouse mode of anti-intercellular sticking molecule-1 single antibody of pure; setting the survival rate of treating group higher than matched group of virus; possessing distinctive difference in pathologic change of lung; displaying the miscellaneous index of the treating group higher than the matched group of virus with disease state, body weight of disease state and change of lung index; possessing distinctive treating action for fowl flu mouse without toxic side action for lung. This invention provides criterion for human and mammal fowl flu.

The invention discloses a Chinese medicine compound composition for treating piglet pullorum. The composition is prepared by mixing the following Chinese medicine raw materials with distilled water, soaking, decocting, filtering to remove impurities, combining filtrates, and concentrating under reduced pressure. The weight percentage of Chinese medicine raw materials is as follows: : Coptidis 5‑10%, Scutellaria baicalensis 5‑10%, Pulsatilla 5‑10%, Qinpi 6‑10%, Dandelion 5‑10%, Pueraria 5‑10%, Galla chinensis 4‑8%, Phellodendron 2‑8%, raw Rhubarb 2‑8%, Forsythia 2‑6%, Honeysuckle 2‑8%, Astragalus 2‑8%. The present invention is based on the cause of the onset of pullorum in piglets, aiming at the common Escherichia coli that causes piglets to infect the disease clinically, and treats it with medicinal prescriptions such as clearing away heat and dampness, clearing away heat and detoxifying, clearing away heat and cooling blood, etc.; Diarrhea and immune-enhancing effects have significant beneficial effects on the treatment of piglet pullorum.